50742-404 : Topotecan 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC50742-404
Labeler: Ingenus Pharmaceuticals, LLC
Product Type: Human Prescription Drug
Drug Name:  Topotecan
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA206962
Rev. Date: 


NDC Package Codes:

  • 50742-404-01: 4 ML IN 1 VIAL (50742‑404‑01)

Active Ingredients:

  • Topotecan Hydrochloride

Dosage Strength:

  • 4 mg/4mL

Pharmaceutical Classes:

  • Topoisomerase Inhibitor [EPC]
  • Topoisomerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0409-0302 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0703-4714 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Teva Parenteral Medicines, Inc.
  • 25021-236 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Sagent Pharmaceuticals
  • 66758-051 Topotecan 1 mg/ml Intravenous Injection by Sandoz Inc
  • 67457-662 Topotecan 1 mg/ml Intravenous Injection, Solution, Concentrate by Mylan Institutional LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50742-404 QR Code

< Prev: 50742-402Next: 50742-405 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 9 December 2016.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA